H3L, also known as histone H3-like protein, is a conserved nuclear protein that participates in chromatin assembly and epigenetic regulation. It maintains genome stability and modulates gene transcription during cell proliferation and differentiation.
Dysregulation of H3L is closely associated with gliomas, neurodevelopmental disorders, and several epigenetic syndromes. It serves as a potential diagnostic marker and therapeutic target. Current research focuses on small-molecule epigenetic modulators and targeted inhibitors, with several candidates under preclinical evaluation for cancer and neurological diseases.
Recombinant Vaccinia virus Envelope protein H3 (OPG108), partial (CSB-EP324943VAA1)
Validated Data
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
The following H3L reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
H3L Antibodies for Vaccinia virus (strain Copenhagen) (VACV)
| Code | Product Name | Species Reactivity | Application |
|---|---|---|---|
| CSB-PA324943ZA01VAA | H3L Antibody | Vaccinia virus | ELISA, WB (ensure identification of antigen) |
H3L Proteins for Vaccinia virus (strain Copenhagen) (VACV)
| Code | Product Name | Source |
|---|---|---|
| CSB-CF324943VAA | Recombinant Vaccinia virus Envelope protein H3 (H3L) | in vitro E.coli expression system |
| CSB-YP324943VAA1 CSB-BP324943VAA1 CSB-MP324943VAA1 CSB-EP324943VAA1-B |
Recombinant Vaccinia virus Envelope protein H3 (OPG108), partial | Yeast Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |
| CSB-EP324943VAA1 | Recombinant Vaccinia virus Envelope protein H3 (OPG108), partial | E.coli |
| CSB-EP324943VAA1d7 | Recombinant Vaccinia virus Envelope protein H3 (OPG108), partial | E.coli |